![no desc](/static/81a7d2502e938304b14d50b497bfe0f2/88aec/ING_8cb027fdf2.png)
Visible benefits on ischemic patients: Cardiac imaging
![Background Vimeo Live Event](/static/41d2f0c3a80127de9100adbf3ad16911/afa5c/EN_BUSINESS_REVIEW_OCT_2021_66_d4887ed88d.png)
About the event
In this conference, the doctor Luis Antonio Machado presents a revision of evidence that support the use of Trimetazidine 80mg for the upbringing of patients that suffer from coronary chronic syndrome.
The doctor explains its metabolic effect, considering a synergy and complimentary action with Beta blockers, offering a significative improvement on the ejection fraction and the LVLGS (Left Ventricular Longitudinal Global Strain) among others. For more information, watch the video ahead:
CAC-05/23-DM-182- For exclusive use of Healthcare professionals
![Background Vimeo Live Event](/static/b0b85a6c0357ca6e1192d2c9e53ba573/88aec/Servier_University_Header_961da436d5.png)
Don't miss our next events!
Subscribe to our newsletter to receive invitations to upcoming events
You can unsubscribe at any time by clicking on the link in our emails.